Two separate findings by a University of Houston nationally recognized expert in systemic lupus erythematosus (SLE or lupus), a chronic autoimmune disease that affects multiple organs including the kidneys, skin, joints and ...
Jun 2, 2022
0
14
The nature of a typical clinical test for lupus nephritis (LN), an inflammation of the kidneys and a leading cause of mortality in lupus patients, is fraught with difficulty. The invasive renal biopsy can be painful and may ...
May 4, 2022
0
0
Lupus (systemic lupus erythematosus), an autoimmune disease in which the body recognizes and attacks its own tissues, can affect many organs, including the kidneys. About fifty percent of patients diagnosed with lupus develop ...
Jan 11, 2022
0
15
Research led by The Ohio State University Wexner Medical Center and College of Medicine found that introducing a single bacterium called segmented filamentous bacteria (SFB) to the gut microbiota causes detrimental effects ...
Jan 7, 2022
0
83
University of Houston Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering, Chandra Mohan, and his team have discovered a difference in urinary biomarker proteins of lupus nephritis (LN) in patients ...
May 5, 2020
0
3
A drug used for cancer therapy has shown promise in reversing kidney damage caused by systemic lupus erythematosus (SLE, or lupus), according to a Yale-led study published April 8 in the journal Science Translational Medicine.
Apr 8, 2020
0
506
A new study found an inverse association between socioeconomic status and certain kidney diseases. The findings appear in an upcoming issue of CJASN.
Feb 20, 2020
0
1
Lupus is a chronic autoimmune disease that can damage any part of the body. When it causes inflammation in the kidneys (called lupus nephritis), they cannot properly remove waste from the blood or control body fluids. Without ...
Feb 3, 2020
0
9
University of Houston researcher Chandra Mohan is reporting in Arthritis Research and Therapy that clotting proteins, both those that promote blood clots (pro-thrombotic) and those that work to dissipate them (thrombolytic), ...
Aug 7, 2019
0
169
Research supported by the Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) provides new insights into tissue damage for these autoimmune conditions. Findings include ...
Jun 19, 2019
0
7
